Overview
The study aimed at study of the Effect of Daclatasvir Plus Sofosbuvir on Angiogenesis in Egyptian Patients With Chronic HCV Infection
Description
The study primary aim was at evaluation of the Effect of Daclatasvir Plus Sofosbuvir on Angiogenesis in Egyptian Patients With Chronic HCV Infection
Eligibility
Inclusion Criteria:
- Chronic HCV patients
Exclusion Criteria:
- HCC.
- HIV or HBV.
- Malignancy.
- Pregnancy.